Read the policies, reports, and plans on how we address issues like racism and reduce our carbon footprint, ensuring our actions align with the highest ethical standards.
In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.
MSF Access pushes for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.
Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.
Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.
Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.
This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.
This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.
This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.
BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.
Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.
Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.
Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.
MSF works with LGBTQI+ populations in many settings over the last 25-30 years. LGBTQI+ people face healthcare disparities with limited access to care and higher disease rates than the general population.
The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.
The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.
The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.
A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.
Noma is a preventable and treatable neglected disease, but 90 per cent of people will die within the first two weeks of infection if they do not receive treatment.
The GeoMSF platform is a dynamic one-stop-shop website for all of MSF's GIS related services and products. Access maps and applications through the catalogue, request geographical support, or produce a map on GeoMSF.
The ‘Hunting and Killings of the Rwandan refugee in Zaire/Congo’ case study describes the constraints, questions and dilemmas faced by Médecins Sans Frontières’ teams in 1996 and 1997 as they attempted to bring assistance to the Rwandan refugees in Eastern Zaire, after their camps had been attacked by the rebel forces supported by the Rwandan army.
Questions and dilemmas:
Is it possible for MSF to publicly extrapolate from the little known conditions of refugees and their health needs despite the fact that it had no access to them
Conversely, given lack of access, should MSF refrain from making predictions?
Is it wise for a humanitarian organisation to predict the worst?
Its team being used to lure refugees from hiding, should MSF cease activities in the area or pursue them, condemning manipulation in the hope of preventing massacres – but at the risk of endangering its teams and other operations in the region?
Should MSF call for the refugees to remain in eastern Zaire, knowing they would face deadly dangers, or participate in their forced repatriation to Rwanda, where their security was not guaranteed either?
This podcast is adapted from the case study “The Hunting and Killing of Rwandan Refugees in Zaire-Congo.1996-1997". In 8 episodes, it investigates MSF's experience in the aftermath of the 1994 Rwandan Tutsi genocide, and in particular, with the impact on local populations and refugees living in the Democratic Republic of Congo (formerly Zaire). The series expresses on the constraints, questions, and dilemmas faced by MSF teams attempting to bring relief to Rwandan refugees and local populations.
